Job description
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Senior Director, Market Access, Italy is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies.
Company
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Keep exploring
Revolution Medicines
Revolution Medicines
Revolution Medicines
Revolution Medicines
Revolution Medicines
Revolution Medicines